03 September 2020>: Clinical Research
Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-κB)-Dependent Pathway
Yu Cheng 123ABCDEG , Xiaofang Che 123A , Simeng Zhang 123C , Tianshu Guo 123F , Xin He 123F , Yunpeng Liu 123AG* , Xiujuan Qu 123AG*DOI: 10.12659/MSM.925019
Med Sci Monit 2020; 26:e925019
Figure 5 CXCR4 and EGFR levels influence the prognosis of patients with gastric cancer. CXCR4 and EGFR levels influence the prognosis of patients with gastric cancer. Kaplan-Meier analysis of overall survival (OS) for EGFR (A) and CXCR4 (B) expressions in all gastric cancer patients (n=56, P=0.001 and P=0.011). (C) Kaplan-Meier analysis of OS for patients with co-expression of CXCR4 and EGFR was undertaken (P=0.002).